Age-related survival after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.

Aims: Since its introduction, alcohol septal ablation (PTSMA) was discussed as treatment option only in elderly symptomatic patients with hypertrophic obstructive cardiomyopathy (HOCM). We report on long-term follow-up after PTSMA with respect to patient's age.

Methods And Results: Between May 2000 and June 2017, we treated 952 consecutive HOCM patients with PTSMA; 133 (14.

Sex-related differences in symptomatic patients with hypertrophic obstructive cardiomyopathy - Time for a new definition?

Introduction: Sex-related differences in diagnosis and treatment of hypertrophic obstructive cardiomyopathy (HOCM) are still unclear. Therefore, we analyzed baseline characteristics of symptomatic patients with indication for alcohol septal ablation (PTSMA) with respect to gender.

Methods And Results: Between 05/2000 and 06/2017 indication for PTSMA was seen in 1014 patients (420 (41.

Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy.

Background: Alcohol-induced infarction for treatment of symptomatic hypertrophic obstructive cardiomyopathy (HOCM) was discussed as a risk factor for increased cardiac mortality during follow-up.

Objectives: This study sought to report on long-term survival after echo-guided alcohol septal ablation (percutaneous transluminal septal myocardial ablation [PTSMA]) in symptomatic patients with HOCM.

Methods: Between May 2000 and June 2017, PTSMA with alcohol injection was performed in 952 patients (age 55.